SCHEMBL19764698

SCHEMBL19764698

c1ccc(C2(c3ccc4c(c3)oc3ccccc34)c3ccccc3Oc3ccccc32)cc1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AHR P35869 2/20 0.41
KMT2A Q03164 5/20 0.41
MEN1 O00255 4/20 0.41
MAPT P10636 4/20 0.41
KDM4E B2RXH2 3/20 0.41
ALDH1A1 P00352 3/20 0.41
HPGD P15428 3/20 0.41
NPC1 O15118 3/20 0.38
RAB9A P51151 3/20 0.38
SMN1; SMN2 Q16637 3/20 0.38
TTR P02766 2/20 0.35
MAOA P21397 4/20 0.35
NPSR1 Q6W5P4 1/20 0.34
LMNA P02545 1/20 0.33
HTR2B P41595 1/20 0.33
GAA P10253 1/20 0.33
CYP1A2 P05177 1/20 0.33
CYP2D6 P10635 1/20 0.33
CYP2C19 P33261 1/20 0.33
GLA P06280 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21975171 0.85 MEN1 (0.45) AHRKMT2AMEN1MAPTKDM4E
SCHEMBL19764699 0.83 LMNA (0.33) KMT2AMEN1MAPTKDM4ESMN1; SMN2
SCHEMBL21888801 0.83 LMNA (0.44) AHRKMT2AMEN1MAPTKDM4E
SCHEMBL19764666 0.82 AHR (0.41) AHRKMT2AMEN1MAPTKDM4E
SCHEMBL21732540 0.81 ALDH1A1 (0.36) AHRKMT2AMEN1MAPTKDM4E
SCHEMBL21732527 0.81 ALDH1A1 (0.34) AHRKMT2AMEN1MAPTKDM4E
SCHEMBL21726030 0.81 PRKDC (0.32)
SCHEMBL25453212 0.80 ALDH1A1 (0.32) AHRKMT2AMEN1MAPTKDM4E
SCHEMBL23028849 0.80 MAPT (0.39) AHRKMT2AMEN1MAPTKDM4E
SCHEMBL21975156 0.79 MAPT (0.45) AHRKMT2AMEN1MAPTKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20180013074-A1 ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES UNIVERSAL DISPLAY CORPORATION 2018-01-11 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180013074-A1 ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES PAX2, EYA2, NLRP1 AHR 2876/4885KMT2A 1926/4885MEN1 2810/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.